Other Assets, Noncurrent of Y-mAbs Therapeutics, Inc. from 30 Sep 2018 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Y-mAbs Therapeutics, Inc. quarterly Other Assets, Noncurrent in USD history and change rate from 30 Sep 2018 to 30 Jun 2025.
  • Y-mAbs Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending 30 Jun 2025 was $646,000, a 95% decline year-over-year.
Source SEC data
View on sec.gov
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $646,000 -$12,814,000 -95% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $718,000 -$10,455,000 -94% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $488,000 -$55,000 -10% 31 Dec 2024 10-Q 08 Aug 2025 2025 Q2
Q3 2024 $18,366,000 +$8,951,000 +95% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $13,460,000 +$1,210,000 +9.9% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $11,173,000 +$2,512,000 +29% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $543,000 -$5,137,000 -90% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $9,415,000 +$3,815,000 +68% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $12,250,000 +$6,501,000 +113% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $8,661,000 +$1,823,000 +27% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $5,680,000 +$2,510,000 +79% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $5,600,000 +$849,000 +18% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $5,749,000 +$956,000 +20% 30 Jun 2022 10-Q 08 Aug 2022 2021 Q3
Q1 2022 $6,838,000 +$2,005,000 +41% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $3,170,000 -$120,000 -3.6% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $4,751,000 +$1,776,000 +60% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $4,793,000 +$4,436,000 +1243% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $4,833,000 +$4,452,000 +1169% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $3,290,000 +$2,920,000 +789% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $2,975,000 +$2,657,000 +836% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $357,000 +$113,000 +46% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $381,000 +$138,000 +57% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $370,000 +$183,000 +98% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $318,000 +$130,000 +69% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $244,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $243,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $187,000 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 $188,000 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.